These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3387717)

  • 1. A random walk model for evaluating clinical trials involving serial observations.
    Hopper JL; Young GP
    Stat Med; 1988 May; 7(5):581-90. PubMed ID: 3387717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial.
    Dudley MN; McLaughlin JC; Carrington G; Frick J; Nightingale CH; Quintiliani R
    Arch Intern Med; 1986 Jun; 146(6):1101-4. PubMed ID: 3521518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin.
    Young GP; Ward PB; Bayley N; Gordon D; Higgins G; Trapani JA; McDonald MI; Labrooy J; Hecker R
    Gastroenterology; 1985 Nov; 89(5):1038-45. PubMed ID: 4043661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missing not at random models for masked clinical trials with dropouts.
    Kang S; Little RJ; Kaciroti N
    Clin Trials; 2015 Apr; 12(2):139-48. PubMed ID: 25627429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical inference on censored data for targeted clinical trials under enrichment design.
    Chen CF; Lin JR; Liu JP
    Pharm Stat; 2013; 12(3):165-73. PubMed ID: 23606647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
    Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial likelihood analysis of within-unit variances in repeated measurement experiments.
    Chinchilli VM; Esinhart JD; Miller WG
    Biometrics; 1995 Mar; 51(1):205-16. PubMed ID: 7766775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Markov process as a general method for nonparametric analysis of right-censored medical data.
    Hillis A; Maguire M; Hawkins BS; Newhouse MM
    J Chronic Dis; 1986; 39(8):595-604. PubMed ID: 3525597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Clostridium difficile colitis.
    Bartlett JG
    Gastroenterology; 1985 Nov; 89(5):1192-5. PubMed ID: 3899842
    [No Abstract]   [Full Text] [Related]  

  • 10. Tests of significance using regression models for ordered categorical data.
    Snapinn SM; Small RD
    Biometrics; 1986 Sep; 42(3):583-92. PubMed ID: 3567291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Step-up testing procedure for multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lin Y; Kwong KS; Cheung SH; Poon WY
    Stat Med; 2014 Sep; 33(21):3629-38. PubMed ID: 24757077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of relapse clinical trials, with application to a comparison of two ulcer treatments.
    Whitehead J
    Stat Med; 1989 Dec; 8(12):1439-54. PubMed ID: 2616934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data.
    Fotouhi AR
    Contemp Clin Trials; 2008 Jul; 29(4):547-54. PubMed ID: 18308644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double SIMEX approach for bivariate random-effects meta-analysis of diagnostic accuracy studies.
    Guolo A
    BMC Med Res Methodol; 2017 Jan; 17(1):6. PubMed ID: 28077079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of permutation (randomization) tests in clinical and experimental pharmacology and physiology.
    Ludbrook J
    Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):673-86. PubMed ID: 7820947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the duration of comparative clinical trials while allowing for cure.
    Sposto R; Sather HN
    J Chronic Dis; 1985; 38(8):683-90. PubMed ID: 4019705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.
    Chen YF; Yang Y; Hung HM; Wang SJ
    Contemp Clin Trials; 2011 Jul; 32(4):592-604. PubMed ID: 21540126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mixture model with random-effects components for clustering correlated gene-expression profiles.
    Ng SK; McLachlan GJ; Wang K; Ben-Tovim Jones L; Ng SW
    Bioinformatics; 2006 Jul; 22(14):1745-52. PubMed ID: 16675467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.